Product Description: Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019.